Key Development Ori Biotech has entered into a 10-year strategic collaboration with an undisclosed biopharmaceutical company, with the agreement valued... Read more
Category: Uncategorized
WOMEN’S TESTOSTERONE USE IS SURGING — AND A PRODUCT GAP IS BECOMING A WOMEN’S HEALTH OPPORTUNITY
Key Development Testosterone use among U.S. women is rising rapidly, particularly among menopausal women experiencing persistently low sexual desire. A... Read more
VINH LONG – UMC: SHIFTING FROM PATIENT REFERRAL TO CAPABILITY TRANSFER
Key Development On September 15, 2026, Vinh Long's Department of Health and the University Medical Center Ho Chi Minh City... Read more
PNEUMOCOCCAL VACCINE ENTERS VIETNAM’S EXPANDED IMMUNIZATION PROGRAM: FROM SELF-PAY ACCESS TO POPULATION-LEVEL PREVENTION
Key Development Vietnam's Ministry of Health is preparing to introduce pneumococcal vaccination into the national Expanded Program on Immunization, extending... Read more
AMALGA – CMC GLOBAL: THE RACE TO BUILD VIETNAM’S HOSPITAL DIGITAL BACKBONE
Key Development New Zealand health technology company Amalga has signed an MoU with CMC Global to expand digital healthcare deployment... Read more
DT120 MOVES LSD CLOSER TO MAINSTREAM MEDICINE AFTER A THIRD PHASE 3 WIN
Key Development Definium Therapeutics has delivered another positive Phase 3 result for DT120 ODT, its fast-dissolving lysergide, or LSD, therapy... Read more
NOVO REBRANDS AS COMPETITIVE PRESSURE FORCES A DEEPER RESET
Key Development Novo Nordisk is adopting “Novo” as its everyday corporate name while introducing a new cultural framework, “The Novo... Read more
FDA OPENS A PATH FOR PSYCHEDELIC THERAPIES: FROM SCIENTIFIC DEBATE TO COMMERCIALIZATION
Key Development On September 14, 2026, the U.S. FDA convened a four-hour public hearing examining how psychedelic medicines could eventually... Read more
GOTISTOBART NEARLY DOUBLES MEDIAN SURVIVAL AS BIONTECH BUILDS A NEW LUNG CANCER GROWTH ENGINE
Key Development BioNTech and OncoC4 have reported updated survival data for gotistobart (BNT316/ONC-392) in patients with metastatic squamous non-small cell... Read more









